Evidence map›Paper›PMID 26092261›Full record

ArticleHarm reduction journal2015

The common sense model applied to hepatitis C: a qualitative analysis of the impact of disease comparison and witnessed death on hepatitis C illness perception.

Stella A Safo, Abigail Batchelder, Deena Peyser, Alain H Litwin

Registry-linked trialOpen access · goldAbstract readEvaluation Study
In one paragraph

Article in Harm reduction journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04162938 (Use of a Patient-Centered Electronic App to Increase Emergency Department Patient's Knowledge on HCV Infection, Disease Progression, and Care to Improve the HCV Care Continuum), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04162938 narecruitingnot on this mapstarted 2022, after this paper: background citation

Use of a Patient-Centered Electronic App to Increase Emergency Department Patient's Knowledge on HCV Infection, Disease Progression, and Care to Improve the HCV Care Continuum

TypeinterventionalSponsorJohns Hopkins UniversityRan2022 to 2026Enrolled308ConditionsHepatitis CArmsPatient-Centered Electronic App
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Stella A SafoDepartment of General Internal Medicine, Albert Einstein College of Medicine, 111 East 210 St., Bronx, NY, 10467, USA. ssafo@montefiore.org.
Abigail BatchelderDepartment of General Internal Medicine, Albert Einstein College of Medicine, 111 East 210 St., Bronx, NY, 10467, USA. abigail.batchelder@ucsf.edu.
Deena PeyserDepartment of General Internal Medicine, Albert Einstein College of Medicine, 111 East 210 St., Bronx, NY, 10467, USA. dspeyser@gmail.com.
Alain H LitwinDepartment of General Internal Medicine, Albert Einstein College of Medicine, 111 East 210 St., Bronx, NY, 10467, USA. alitwin@montefiore.org.
Albert Einstein College of Medicine · USRutgers Sexual and Reproductive Health and Rights · NLUniversity of California System · US

Funding

Special Animal CoreP30DK041296 · NIDDK · YESHIVA UNIVERSITY · PI WOLKOFF, ALLAN W · 1989 to 2018
$22.9M
Core-010UL1TR001073 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI KELLER, MARLA J, SHAMOON, HARRY · 2013 to 2017
$21.3M
Intensive Models of HCV Care for Injection Drug UsersR01DA034086 · NIDA · CLEMSON UNIVERSITY · PI LITWIN, ALAIN HARRIS · 2012 to 2016
$3.7M
Directly Observed Hepatitis C Treatment in Methadone ClinicsK23DA022454 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI LITWIN, ALAIN HARRIS · 2008 to 2012
$904k
NCATS NIH HHS UL1 TR001073NIDA NIH HHS K23 DA022454NIDA NIH HHS R01 DA034086NIDDK NIH HHS P30 DK041296
6 · The paper itself

Abstract

backgroundHepatitis C virus (HCV) accounts for 15,000 deaths in the United States yearly because people living with HCV are not identified in time to seek treatment, are ineligible for or refuse treatment, or face structural impediments to obtaining treatment such as lack of access to health care or lack of insurance. People who inject drugs (PWID) comprise a large proportion-estimates of up to 60-70%-of current and new HCV infected individuals and face many barriers to completing HCV treatment.

methodsWe conducted 30 qualitative semi-structured interviews of current and former PWID seeking HCV treatment at an opioid-agonist treatment facility in New York City. We used thematic analysis, informed by grounded theory, to examine perceptions of HCV and decisions to initiate HCV treatment. We analyzed the themes that emerged via the common sense model (CSM) of illness perception theoretical framework.

resultsUsing thematic analyses, two major themes emerged related to engagement in HCV treatment. First, participants independently compared HCV to HIV, and in so doing, emphasized the potential fatality of HCV and the need for treatment. Second, participants described witnessing others suffer or die from untreated HCV and expressed how these recollections impacted their desire to undergo treatment themselves. Together, these themes contributed to the way participants perceived HCV and informed their decisions to initiate treatment. Both themes reflect the CSM's "self-regulation" process, which posits that understanding the causes and consequences of an illness impacts one's ability to seek treatment to overcome this illness state.

conclusionsThis paper offers insight into how clinicians can better understand and utilize HCV illness perceptions to evaluate willingness to engage in HCV treatment among PWID considering antiviral treatment modalities.

Indexed as

Attitude to DeathHealth Knowledge, Attitudes, PracticeFemaleHealth Services AccessibilityHealth Services Needs and DemandHepatitis CHumansInterviews as TopicMaleMiddle AgedNew York CitySubstance Abuse, Intravenous

Identifiers

PMID26092261
PMCPMC4477484
OpenAlexW1517049034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.